4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-308922
EVP, Chief Development Officer gave up 1,101 shares (to pay taxes)
- EVP, Chief Development Officer acquired 3,874 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Forbes William P · EVP, Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-19 | Exercise or conversion : show line 1 in the form | +3,874 | 225,485 | D | ||
| 2026-07-19 | Shares withheld for taxes : show line 2 in the form | −1,101 | $0.47 | $517 | 224,384 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-19 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −3,874 | 23,246 | D |
Loading xslF345X06/ownership.xml…